Glycorex Transplantation Investor Relations Material
Latest events
Q1 2025
23 May, 2025
Q4 2024
27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Glycorex Transplantation
Access all reports
Glycorex Transplantation is a Swedish biotechnology company that develops and markets medical devices for organ and blood compatibility. The company’s core technology removes specific antibodies from blood, enabling safer organ transplants and transfusions. It serves hospitals and healthcare providers globally. Glycorex Transplantation is headquartered in Lund, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
GTAB
Country
🇸🇪 Sweden